NCT00775359View on ClinicalTrials.gov

Bioequivalence Study of Fenofibrate 160mg Tablets Under Fed Conditions

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

August 31, 2002

Primary Completion Date

September 30, 2002

Study Completion Date

October 31, 2002

Conditions
Healthy
Interventions
DRUG

Fenofibrate 160 mg tablets

Trial Locations (1)

85044

MDS Pharma Services, Phoenix

All Listed Sponsors
lead

Ranbaxy Laboratories Limited

INDUSTRY

NCT00775359 - Bioequivalence Study of Fenofibrate 160mg Tablets Under Fed Conditions | Biotech Hunter | Biotech Hunter